Word

CLEAN CELLS

Status

Dead

Status Code

602

Status Date

Thursday, May 18, 2023

Serial Number

79316561

Mark Type

4

Filing Date

Thursday, January 7, 2021

Abandoned Date

Monday, May 1, 2023

Trademark Owner History

CLEAN CELLS

Classifications

41 Training in the field of health, biotechnology, biomedicine, bacteriology and bioproduction; moderating workshops and seminars in the field of health, biotechnology, biomedicine, bacteriology and bioproduction; provision of online training in the form of courses, seminars, workshops, non-downloadable webinars in the fields of health, biotechnology, biomedicine, bacteriology and bioproduction; provision of educational materials online in the nature of e-books, magazines, brochures, journals, newsletters in the field of health ; provision of non-downloadable online electronic publications in the nature of e-books, magazines, brochures, journals, newsletters in the field of health, biotechnology, biomedicine, bacteriology and bioproduction

5 Pharmaceutical preparations for the treatment of immune system related diseases and disorders, for the treatment of viral and infectious diseases, for the treatment of joint disease, for the treatment of cancer; pharmaceutical products for the treatment of immune system related diseases and disorders, for the treatment of viral and infectious diseases, for the treatment of joint disease, for the treatment of cancer ; pharmaceutical substances for the treatment of immune system related diseases and disorders, for the treatment of viral and infectious diseases, for the treatment of joint disease, for the treatment of cancer ; preparations for vaccines namely vaccine stabilizers, adjuvants, therapeutic vaccines, viral vaccines; vaccines; cells for medical use; stem cells for medical use; living cells for medical use; diagnostic kits consisting of diagnostic agents, preparations and substances for medical use for testing of bodily fluids for use in disease detection; chemical and biochemical reagents for medical and pharmaceutical use; biological reagents, namely, biological preparations for detection, analysis and quantification of microbial contaminants for medical diagnostic purposes for research; chemical reagents and culture media for medical and pharmaceutical diagnostics; medical diagnostic tests comprised primarily of swabs, testing strips and reagents for testing for the presence of pathogens and infections; medical diagnostic kits comprising medical diagnostic tests comprised primarily of swabs, testing strips and reagents for testing for the presence of pathogens and infections; medical diagnostic kits comprising medical diagnostic tests comprised primarily of swabs, testing strips and reagents for analyzing organic liquids of microorganisms; diagnostic kits for medical use composed of swabs, testing strips and reagents for detection of viruses, bacteria, fungi, pathogens and parasites

44 Storage of human cells for medical purposes; medical services namely storage of stem cells; storage of human cells, cell banks, viral batches and all derived biological products; storage of biological tissues, biological cells and biological cellular components for medical and scientific use; storage of human cells, cell components and tissues intended for cell and cell component treatments and transplantations; cell bank services; Human tissue analysis services for medical treatments; genetic analysis for medical treatment; carrying out disease diagnoses; genetic analysis for medical use; storage of human cells, cell banks, viral batches and all derived biological products

10 Diagnostic devices for medical use for detection of viruses, bacteria, fungi, pathogens and parasites; medical apparatus for biological sample analysis for medical diagnostic purposes; analysis devices for identification of bacteria for medical purposes

42 Medical research; biological research; scientific research; bacteriological research; research in biochemistry; biotechnological research; research in the field of pharmaceutical products; pharmaceutical research and development; pharmaceutical, biomedical, agrochemical, chemical, bacteriological research and development for the pharmaceutical, biomedical, agrochemical, chemical, bacteriological industry; scientific and medical research and development; pharmaceutical, biomedical, agrochemical, chemical, bacteriological research services in the field of proteins, antibodies, microorganisms and cells; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; stem cell research; research and development of vaccines and medicines; research and testing in bacteriology; research and development services in the field of antibody technology; provision of information relating to medical and scientific research in the field of pharmaceutical products; Scientific and technological services, namely research, testing and analysis in the fields of biotechnology, biomedicine, bacteriology and bioproduction for research purposes; Scientific and technological services, namely research, testing and analysis in the field of biotechnology, biomedicine, bacteriology and bioproduction; consultancy with respect to pharmaceutical research and development; provision of information regarding medical and scientific research in the field of pharmaceutical products and clinical trials; quality control for others; quality assessments as part of quality control for others; pharmaceutical, biomedical, agrochemical, chemical, bacteriological research in the field of gene therapy; testing, analysis and evaluation of services for third parties to determine compliance with certification standards; development of medicines including production of raw materials; development of biological medicines including production of raw materials

Trademark Events

Jul 29, 2021

Sn Assigned For Sect 66a Appl From Ib

Jul 30, 2021

New Application Office Supplied Data Entered

Jul 30, 2021

Assigned To Examiner

Aug 3, 2021

Application Filing Receipt Mailed

Aug 7, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Aug 6, 2021

Non-Final Action Written

Aug 23, 2021

Refusal Processed By Mpu

Aug 23, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Sep 11, 2021

Refusal Processed By Ib

Feb 23, 2022

Teas Response To Office Action Received

Feb 23, 2022

Correspondence Received In Law Office

Feb 24, 2022

Teas/Email Correspondence Entered

Feb 24, 2022

Assigned To Lie

Mar 30, 2022

Non-Final Action E-Mailed

Mar 30, 2022

Non-Final Action Written

Mar 30, 2022

Notification Of Non-Final Action E-Mailed

Sep 29, 2022

Teas Response To Office Action Received

Sep 29, 2022

Correspondence Received In Law Office

Sep 30, 2022

Teas/Email Correspondence Entered

Jan 23, 2023

Notification Of Possible Opposition - Processed By Ib

Oct 28, 2022

Final Refusal E-Mailed

Oct 28, 2022

Notification Of Final Refusal Emailed

Oct 28, 2022

Final Refusal Written

Jan 4, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 4, 2023

Notification Of Possible Opposition Sent To Ib

May 18, 2023

Abandonment - Failure To Respond Or Late Response

May 18, 2023

Abandonment Notice Mailed - Failure To Respond

May 19, 2024

Final Disposition Notice Created, To Be Sent To Ib

May 20, 2024

Final Disposition Notice Sent To Ib

Jun 11, 2024

Final Decision Transaction Processed By Ib

May 18, 2023

Abandonment Notice E-Mailed - Failure To Respond